Aspirin May Lower HCC Risk in Patients With Hepatitis B Aspirin May Lower HCC Risk in Patients With Hepatitis B
A new study finds that daily low-dose aspirin may decrease the risk for hepatocellular carcinoma in patients with chronic hepatitis B infection.Medscape Medical News
Source: Medscape Infectious Diseases Headlines - Category: Infectious Diseases Tags: Gastroenterology News Source Type: news
More News: Aspirin | Cancer & Oncology | Carcinoma | Gastroenterology | Hepatitis | Hepatitis B | Hepatocellular Carcinoma | Infectious Diseases | Liver Cancer | Study